Pralnacasan
Alternative Names: HMR 3480; VX 740Latest Information Update: 18 Aug 2009
At a glance
- Originator Vertex Pharmaceuticals
- Class Anti-inflammatories; Antirheumatics; Azepines; Isoquinolines; Pyridazines; Small molecules
- Mechanism of Action Caspase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Inflammatory bowel diseases; Osteoarthritis; Psoriasis; Rheumatoid arthritis
Most Recent Events
- 31 Dec 2005 Phase-II clinical trials resumed in Rheumatoid arthritis in Canada (PO)
- 31 Dec 2005 Phase-II clinical trials resumed in Rheumatoid arthritis in USA (PO)
- 11 Mar 2005 Suspended - Phase-II for Osteoarthritis in USA (PO)